Karel Caca
About
Karel Caca is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, Karel Caca has authored 142 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Surgery, 69 papers in Pulmonary and Respiratory Medicine and 47 papers in Oncology. Recurrent topics in Karel Caca's work include Gastric Cancer Management and Outcomes (39 papers), Esophageal and GI Pathology (35 papers) and Gastrointestinal Tumor Research and Treatment (23 papers). Karel Caca is often cited by papers focused on Gastric Cancer Management and Outcomes (39 papers), Esophageal and GI Pathology (35 papers) and Gastrointestinal Tumor Research and Treatment (23 papers). Karel Caca collaborates with scholars based in Germany, United States and Switzerland. Karel Caca's co-authors include Joachim Mössner, Arthur Schmidt, Frieder Berr, Marcus Wiedmann, Beate Appenrodt, Jaime Bosch, Benjamin Meier, Dominik Hüster, Péter Ferenci and Juan Carlos García‐Pagán and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Karel Caca
135 papers receiving 6.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Karel Caca Germany | 41 | 3.7k | 2.3k | 1.6k | 1.4k | 1.3k | 142 | 6.4k | ||
| Jérôme Dumortier France | 40 | 2.4k 0.7× | 683 0.3× | 862 0.5× | 3.7k 2.6× | 2.9k 2.2× | 284 | 6.4k | ||
| A P Mowat United Kingdom | 36 | 2.0k 0.5× | 991 0.4× | 356 0.2× | 1.5k 1.0× | 1.1k 0.9× | 112 | 4.1k | ||
| Barbara F. Banner United States | 39 | 1.1k 0.3× | 579 0.3× | 968 0.6× | 1.0k 0.7× | 1.4k 1.0× | 137 | 4.7k | ||
| Guido Schumacher Germany | 30 | 1.2k 0.3× | 975 0.4× | 815 0.5× | 689 0.5× | 341 0.3× | 96 | 2.7k | ||
| Ulrich T. Hopt Germany | 42 | 3.8k 1.0× | 1.9k 0.8× | 3.8k 2.3× | 374 0.3× | 691 0.5× | 196 | 7.6k | ||
| Claudio Avellini Italy | 36 | 1.6k 0.4× | 623 0.3× | 503 0.3× | 863 0.6× | 1.2k 0.9× | 115 | 3.7k | ||
| Seiji Kawano Japan | 32 | 1.2k 0.3× | 1.1k 0.5× | 653 0.4× | 105 0.1× | 471 0.4× | 255 | 4.7k | ||
| Chun‐Nan Yeh Taiwan | 41 | 2.7k 0.7× | 2.2k 0.9× | 1.7k 1.0× | 727 0.5× | 676 0.5× | 280 | 5.5k | ||
| Josep M. Piqué Spain | 31 | 2.4k 0.6× | 1.2k 0.5× | 2.7k 1.6× | 570 0.4× | 499 0.4× | 52 | 4.9k | ||
| Byung Ik Kim South Korea | 37 | 1.4k 0.4× | 944 0.4× | 1.0k 0.6× | 919 0.6× | 1.3k 1.0× | 125 | 3.6k |
Countries citing papers authored by Karel Caca
Since
Specialization
Citations
This map shows the geographic impact of Karel Caca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Caca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Caca more than expected).
Fields of papers citing papers by Karel Caca
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Karel Caca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Caca. The network helps show where Karel Caca may publish in the future.
Co-authorship network of co-authors of Karel Caca
This figure shows the co-authorship network connecting the top 25 collaborators of Karel Caca. A scholar is included among the top collaborators of Karel Caca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Caca. Karel Caca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Meier, Benjamin, et al.. (2024). Propensity score-matched retrospective cohort study of endoscopic ultrasound-guided gastroenterostomy and enteral stenting for malignant gastric outlet obstruction. Surgical Endoscopy. 38(4). 2078–2085.
2.
Al‐Batran, Salah‐Eddin, Sylvie Lorenzen, Jorge Riera, et al.. (2024). Effect of chemotherapy/targeted therapy alone vs. chemotherapy/targeted therapy followed by radical surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction: The IKF-575/RENAISSANCE phase III trial.. Journal of Clinical Oncology. 42(17_suppl). LBA4001–LBA4001.
3.
Wannhoff, Andreas, Todd H. Baron, Mouen A. Khashab, et al.. (2024). EUS GASTROENTEROSTOMY (EUS-GE) FOR TREATMENT OF GASTRIC OUTLET OBSTRUCTION IN PATIENTS WITH ACUTE NECROTIZING PANCREATITIS. Gastrointestinal Endoscopy. 99(6). AB886–AB886.
4.
Fuhrmann, Valentin, Jürgen Koscielny, Tilo Andus, et al.. (2023). Einsatz von spezifischen Antidots bei DOAK-assoziierter schwerer gastrointestinaler Blutung – ein Expertenkonsensus. Zeitschrift für Gastroenterologie. 62(5). 759–768.
5.
Meier, Benjamin, Andreas Wannhoff, U Denzer, et al.. (2022). Over-the-scope-clips versus standard treatment in high-risk patients with acute non-variceal upper gastrointestinal bleeding: a randomised controlled trial (STING-2). Gut. 71(7). 1251–1258.
6.
Sturm, Lukas, Dominik Bettinger, Christoph Klinger, et al.. (2021). Validation of color Doppler ultrasound and computed tomography in the radiologic assessment of non-malignant acute splanchnic vein thrombosis. PLoS ONE. 16(12). e0261499–e0261499.
7.
Walter, Benjamin, Leopold Ludwig, Nektarios Dikopoulos, et al.. (2020). Smartphone Application to Reinforce Education Increases High-Quality Preparation for Colorectal Cancer Screening Colonoscopies in a Randomized Trial. Clinical Gastroenterology and Hepatology. 19(2). 331–338.e5.
8.
Schmidt, Arthur, Stefan Gölder, Martin Goetz, et al.. (2018). Over-the-Scope Clips Are More Effective Than Standard Endoscopic Therapy for Patients With Recurrent Bleeding of Peptic Ulcers. Gastroenterology. 155(3). 674–686.e6.
9.
Wannhoff, Andreas, et al.. (2017). Endoscopic jejunojejunostomy by use of a lumen-apposing self-expandable metal stent for treatment of obstructed efferent loop after subtotal gastrectomy with Roux-en-Y-reconstruction. VideoGIE. 2(10). 276–278.
10.
Meier, Benjamin & Karel Caca. (2016). Endoscopic and Photodynamic Therapy of Cholangiocarcinoma. Visceral Medicine. 32(6). 411–413.
11.
Schmidt, Arthur, Tilman Pickartz, Markus M. Lerch, et al.. (2016). Effective treatment of benign biliary strictures with a removable, fully covered, self‐expandable metal stent: A prospective, multicenter European study. United European Gastroenterology Journal. 5(3). 398–407.
12.
Sinn, Marianne, Sven Bischoff, Oliver Nehls, et al.. (2012). Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany. Onkologie. 35(12). 755–760.
13.
Teich, Niels, Ali A. Aghdassi, Julia Fischer, et al.. (2010). Optimal Timing of Oral Refeeding in Mild Acute Pancreatitis. Pancreas. 39(7). 1088–1092.
14.
García‐Pagán, Juan Carlos, Karel Caca, Christophe Bureau, et al.. (2008). An early decission for ptfe-tips improves survival in high risk cirrhotic patients admitted with an acute variceal bleeding. a multicenter rct. Hepatology. 48(4).
15.
Rothstein, Richard, Charles J. Filipi, Karel Caca, et al.. (2006). Endoscopic Full-Thickness Plication for the Treatment of Gastroesophageal Reflux Disease: A Randomized, Sham-Controlled Trial. Gastroenterology. 131(3). 704–712.
16.
Wiedmann, Marcus, et al.. (2006). Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib. Anti-Cancer Drugs. 17(7). 783–795.
17.
Schoppmeyer, Konrad, Marcus Wiedmann, André Liebmann, et al.. (2006). Radiochemotherapy Followed by Gemcitabine and Capecitabine in Extrahepatic Bile Duct Cancer. American Journal of Clinical Oncology. 29(6). 576–582.
18.
Hermann, W., Karel Caca, Thomas Villmann, et al.. (2002). Genotype Correlation with Fine Motor Symptoms in Patients with Wilson’s Disease. European Neurology. 48(2). 97–101.
19.
Caca, Karel, et al.. (2001). Photodynamic therapy of non-resectable cholangio carcinoma — A randomized prospective study — First results. Gastrointestinal Endoscopy. 53(5). AB85–AB85.
20.
Caca, Karel, Péter Ferenci, Hans-Jürgen Kühn, et al.. (2001). High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype–genotype analysis. Journal of Hepatology. 35(5). 575–581.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jérôme Dumortier Breakdown of academic impact, for papers by A P Mowat Breakdown of academic impact, for papers by Barbara F. Banner Breakdown of academic impact, for papers by Guido Schumacher Breakdown of academic impact, for papers by Ulrich T. Hopt Breakdown of academic impact, for papers by Claudio Avellini Breakdown of academic impact, for papers by Seiji Kawano Breakdown of academic impact, for papers by Chun‐Nan Yeh Breakdown of academic impact, for papers by Josep M. Piqué Breakdown of academic impact, for papers by Byung Ik Kim